OS12.2 Targeting epigenetic pathways in the treatment of recurrent high-grade glioma

BACKGROUND: High grade glioma (HGG) patients develop resistance to standard treatment leading to disease progression and limited life expectancy. Advances in the molecular characterisation of treatment-naïve HGGs based on next-generation sequencing and DNA methylation analyses have led to a better d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Hau, A, Houben, L, Klein, E, Oudin, A, Stieber, D, Flies, B, Kaoma, T, Azuaje, F, Fritah, S, Bjerkvig, R, Hertel, F, Mittelbronn, M, Golebiewska, A, Niclou, S P
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Oral Presentations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6795588/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.074
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars